series-c-plus
Stage
1
Investors
About
Foghorn Therapeutics develops therapies targeting the epigenetic machinery to treat cancer and other serious diseases by modulating chromatin regulatory proteins.
Explore Foghorn Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.